Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354743 · ClinicalTrials.gov registry record · Phase 4
Upper Facial Remodeling With Perlane-L and Dysport
A Phase 4 study, sponsored by Beer, Kenneth R., M.D., PA.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01354743: Completed Phase 4 study, sponsored by Beer, Kenneth R., M.D., PA.
NCT01354743 is a Phase 4 study that has completed, run by Beer, Kenneth R., M.D., PA. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01354743, a Phase 4 study, has completed, sponsored by Beer, Kenneth R., M.D., PA.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to provide data to support combination treatment of the upper face with Perlane-L® and Dysport™. This study will assess the outcome of upper face rejuvenation in the temporal fossa; outcome of glabella and/or periorbital regions will also be assessed as a secondary endpoint.
Primary Outcome
Subjects are assessed from a Four Point Temporal Atropy scale at baseline(must present with a 1 or 2 score).Subject will be assessed at 1 month with additonal treatment if needed and return at month 3,6, and 9 months and be assessed with the Four Point Atrophy Scale.
Interventions
- DRUG Dysport
- DEVICE Perlane L
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-05 |
| Phase | Phase 4 |
What the finished NCT01354743 record still lists
NCT01354743 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Dysport is the first listed.
NCT01354743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01354743 about?
NCT01354743 is a clinical study titled "Upper Facial Remodeling With Perlane-L and Dysport". The purpose of this study is to provide data to support combination treatment of the upper face with Perlane-L® and Dysport™. This study will assess the outcome of upper face rejuvenation in the temporal fossa; outcome of glabella and/or periorbital regions will also be assessed as a secondary endpo...
What is the current status of trial NCT01354743?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01354743?
The interventions under investigation include: Dysport (DRUG), Perlane L (DEVICE).
Who is sponsoring clinical trial NCT01354743?
This trial is sponsored by Beer, Kenneth R., M.D., PA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01354743's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia